APA (7th ed.) Citation

Benjamin S Collyer, Michael A Irvine, T Deidre Hollingsworth, Mark Bradley, & Roy M Anderson. (2020). Defining a prevalence level to describe the elimination of Lymphatic Filariasis (LF) transmission and designing monitoring & evaluating (M&E) programmes post the cessation of mass drug administration (MDA). Public Library of Science (PLoS).

Chicago Style (17th ed.) Citation

Benjamin S Collyer, Michael A Irvine, T Deidre Hollingsworth, Mark Bradley, and Roy M Anderson. Defining a Prevalence Level to Describe the Elimination of Lymphatic Filariasis (LF) Transmission and Designing Monitoring & Evaluating (M&E) Programmes Post the Cessation of Mass Drug Administration (MDA). Public Library of Science (PLoS), 2020.

MLA (9th ed.) Citation

Benjamin S Collyer, et al. Defining a Prevalence Level to Describe the Elimination of Lymphatic Filariasis (LF) Transmission and Designing Monitoring & Evaluating (M&E) Programmes Post the Cessation of Mass Drug Administration (MDA). Public Library of Science (PLoS), 2020.